🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the effect of usual treatment of docetaxel che...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-03
Trial ID
NCT05408845
This phase Ib trial tests the safety, side effects, and best dose of leflun...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-05-13
Trial ID
NCT06454383
This phase III trial studies whether adding apalutamide to the usual treatm...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2020-04-16
Trial ID
NCT04134260
This phase III trial compares stereotactic body radiation therapy (SBRT), (...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-12-14
Trial ID
NCT05946213
This phase II trial studies how well combination chemotherapy works in trea...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-10-19
Trial ID
NCT04322318
Treatments Being Tested
This phase I trial tests the safety and side effects of B-cell activating f...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-17
Trial ID
NCT07758673
Treatments Being Tested
This phase I/II trial tests the safety, side effects best dose and effect o...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-06-23
Trial ID
NCT07468136
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067
This early phase I trial investigates how well radiation therapy, plasma ex...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2020-12-14
Trial ID
NCT04581382
This phase II trial studies the effect of rogaratinib in treating patients ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-05-03
Trial ID
NCT04595747